INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 145 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $292,485 | -22.5% | 9,250 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $377,215 | +39.6% | 9,250 | +27.6% | 0.00% | 0.0% |
Q1 2023 | $270,208 | +5.2% | 7,250 | -1.5% | 0.00% | 0.0% |
Q4 2022 | $256,790 | -56.5% | 7,360 | -30.2% | 0.00% | -66.7% |
Q3 2022 | $590,000 | +10.1% | 10,538 | +1.7% | 0.00% | +50.0% |
Q2 2022 | $536,000 | -28.8% | 10,360 | -0.0% | 0.00% | -33.3% |
Q1 2022 | $753,000 | -31.2% | 10,362 | +11.9% | 0.00% | 0.0% |
Q4 2021 | $1,095,000 | -10.4% | 9,262 | +1.7% | 0.00% | -25.0% |
Q3 2021 | $1,222,000 | -17.2% | 9,110 | 0.0% | 0.00% | -20.0% |
Q2 2021 | $1,475,000 | +101.8% | 9,110 | 0.0% | 0.01% | +66.7% |
Q1 2021 | $731,000 | +65.8% | 9,110 | +12.3% | 0.00% | +50.0% |
Q4 2020 | $441,000 | +67.7% | 8,110 | -58.9% | 0.00% | 0.0% |
Q3 2019 | $263,000 | -18.6% | 19,730 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $323,000 | -15.0% | 19,730 | -11.4% | 0.00% | 0.0% |
Q1 2019 | $380,000 | +26.2% | 22,260 | +0.9% | 0.00% | 0.0% |
Q4 2018 | $301,000 | +5.2% | 22,060 | +120.6% | 0.00% | 0.0% |
Q3 2018 | $286,000 | -34.7% | 10,000 | -37.5% | 0.00% | -33.3% |
Q2 2018 | $438,000 | – | 16,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |